Oliveira Ana, Pinto de Almeida Teresa, Lobo Inês, Machado Susana, Selores Manuela
Hospital de Santo António, Centro Hospitalar do Porto, Portugal.
Dermatol Online J. 2012 Jan 15;18(1):8.
Langerhans cell histiocytosis (LCH) is a heterogeneous group of diseases characterized by a pathological proliferation of cells phenotypically similar to Langerhans cells. The disease course is variable, alternating between resolving and potentially fatal forms. The diagnosis is based on clinical appearance and confirmed by CD1a positivity and / or immunohistochemistry. We report the case of a male child of 3 months with two different presentations of Langerhans cell-histiocytosis (LCH) at different times. The first presentation was classified as a self-healing LCH (formerly known as Hashimoto-Pritzker). The last presentation, although clinically suggestive of Letterer-Siwe (former designation), was not associated with systemic disease. This emphasizes that LCH cannot be compartmentalized into four groups, but considered a single disease with a wide spectrum of clinical presentations. This case underscores the importance of frequent and long-term follow-up of these patients.
朗格汉斯细胞组织细胞增多症(LCH)是一组异质性疾病,其特征为表型与朗格汉斯细胞相似的细胞发生病理性增殖。病程多变,可在缓解型和潜在致命型之间交替。诊断基于临床表现,并通过CD1a阳性和/或免疫组织化学得以证实。我们报告了一名3个月大男童的病例,其在不同时间出现了两种不同表现形式的朗格汉斯细胞组织细胞增多症(LCH)。首次表现被归类为自愈性LCH(以前称为桥本-普里茨克病)。最后一次表现虽然临床提示勒-雪病(以前的命名),但未伴有全身性疾病。这强调了LCH不能被划分为四组,而应被视为一种具有广泛临床表现的单一疾病。该病例凸显了对这些患者进行频繁和长期随访的重要性。